mesalamine has been researched along with Abnormalities, Drug-Induced in 5 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Källén, B | 1 |
| Nørgård, B | 1 |
| Fonager, K | 1 |
| Pedersen, L | 1 |
| Jacobsen, BA | 1 |
| Sørensen, HT | 1 |
| Rahimi, R | 1 |
| Nikfar, S | 1 |
| Rezaie, A | 1 |
| Abdollahi, M | 1 |
| Bell, CM | 1 |
| Habal, FM | 1 |
| Sachar, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Sulfasalazine on CRH Levels in Pregnant Women With a History of Pre-Term Birth: A Randomized Controlled Trial[NCT05703425] | Phase 2 | 50 participants (Anticipated) | Interventional | 2023-03-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for mesalamine and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; | 2008 |
4 other studies available for mesalamine and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Maternal use of 5-aminosalicylates in early pregnancy and congenital malformation risk in the offspring.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Infant, | 2014 |
Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colitis | 2003 |
Safety of topical 5-aminosalicylic acid in pregnancy.
Topics: Abnormalities, Drug-Induced; Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal | 1997 |
Exposure to mesalamine during pregnancy increased preterm deliveries (but not birth defects) and decreased birth weight.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Birth Weight; Case-Cont | 1998 |